{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Free Realtime Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "epsTrailingTwelveMonths": -1.76, "epsForward": -1.04, "sharesOutstanding": 39470100, "bookValue": 3.857, "fiftyDayAverage": 8.1934, "fiftyDayAverageChange": -1.3134003, "fiftyDayAverageChangePercent": -0.16029978, "twoHundredDayAverage": 13.578314, "twoHundredDayAverageChange": -6.6983137, "twoHundredDayAverageChangePercent": -0.49330968, "marketCap": 313308320, "forwardPE": -6.615385, "priceToBook": 1.7837697, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "tradeable": false, "cryptoTradeable": false, "currency": "SEK", "financialCurrency": "SEK", "regularMarketOpen": 6.78, "averageDailyVolume3Month": 87700, "averageDailyVolume10Day": 82467, "fiftyTwoWeekLowChange": 0.61000013, "fiftyTwoWeekLowChangePercent": 0.0972887, "fiftyTwoWeekRange": "6.27 - 49.95", "fiftyTwoWeekHighChange": -43.07, "fiftyTwoWeekHighChangePercent": -0.86226225, "fiftyTwoWeekLow": 6.27, "fiftyTwoWeekHigh": 49.95, "earningsTimestamp": 1687345140, "earningsTimestampStart": 1687345140, "earningsTimestampEnd": 1687345140, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "firstTradeDateMilliseconds": 1490770800000, "priceHint": 2, "marketState": "REGULAR", "regularMarketChange": 0.099999905, "regularMarketTime": 1684143195, "regularMarketDayHigh": 6.89, "regularMarketDayRange": "6.51 - 6.89", "regularMarketDayLow": 6.51, "regularMarketVolume": 22537, "regularMarketPreviousClose": 6.78, "bid": 6.75, "ask": 6.87, "bidSize": 0, "askSize": 0, "fullExchangeName": "Stockholm", "regularMarketChangePercent": 1.4749248, "regularMarketPrice": 6.88, "exchangeTimezoneName": "Europe/Stockholm", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "esgPopulated": false, "exchange": "STO", "shortName": "Biovica International AB ser. B", "longName": "Biovica International AB (publ)", "messageBoardId": "finmb_253513502", "market": "se_market", "symbol": "BIOVIC-B.ST"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Dag HammarskjOelds vAeg 54B", "address2": "Uppsala Science Park", "city": "Uppsala", "zip": "752 37", "country": "Sweden", "phone": "46 1 84 44 48 30", "website": "https://www.biovica.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Biovica International AB (publ), a biotechnology company, develops and commercializes blood-based biomarker assays that enhance the monitoring and predicting of cancer therapies in Sweden and internationally. It primarily focuses on breast cancer. The company develops DiviTum, a biomarker assay that measures the activity of the enzyme thymidine kinase-1 in blood serum or cell cultures. It serves cancer institutes, pharmaceutical companies, and collaborative groups. The company was incorporated in 2008 and is headquartered in Uppsala, Sweden.", "fullTimeEmployees": 33, "companyOfficers": [{"maxAge": 1, "name": "Mr. Anders  Rylander", "age": 52, "title": "CEO & Director", "yearBorn": 1970, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Anders  Moren", "title": "Chief Financial Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Tomas  Andersson", "age": 62, "title": "VP of Operations", "yearBorn": 1960, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Henrik  Winther D.V.M., Ph.D.", "age": 56, "title": "Sr. VP of Bus. Devel.", "yearBorn": 1966, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Warren  Cresswell", "age": 54, "title": "Pres of Americas", "yearBorn": 1968, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Mattias  Bergqvist", "age": 52, "title": "VP of Clinical Devel.", "yearBorn": 1970, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}